US proposes to skip inspection of firms audited by a GHTF member
This article was originally published in Clinica
Executive Summary
Device manufacturers whose establishments have been audited under one of the regulatory systems of a founding member of the Global Harmonization Task Force might be able to avoid undergoing a re-inspection by the US Food and Drug Administration for a period of one year.